Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involving patients as research partners exemplified by the development and evaluation of a communication-skills training programme (KOKOS-Rheuma).

Zeitschrift fur Rheumatologie·2020
Same author

Disease-related everyday communication of persons with rheumatic and musculoskeletal diseases-Results of a participatory research project.

Patient education and counseling·2016
Same author

[Assessing Social Resources in the Chronically Ill: Development and Initial Psychometric Testing of an Ego-centered Network Generator].

Die Rehabilitation·2016
Same author

Health-related quality of life in rehabilitants with different cancer entities.

European journal of cancer care·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Factors influencing pairbond stability in convict cichlids (Cichlasoma nigrofasciatum).

Behavioural processes·2014

Related Experiment Video

Updated: Jul 12, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Lovastatin induces mitotic abnormalities in various cell lines.

J Lamprecht1, C Wójcik, M Jakóbisiak

  • 1Department of Histology and Embryology, Medical University of Warsaw, Chalubińskiego 5, Warsaw, 02-004, Poland.

Cell Biology International
|October 21, 1999
PubMed
Summary

Lovastatin, an anti-atherosclerotic drug, disrupts cell division (mitosis) by affecting chromosome movement and centromere function. These effects are reversible and linked to lovastatin

More Related Videos

Live Cell Imaging of Chromosome Segregation During Mitosis
06:39

Live Cell Imaging of Chromosome Segregation During Mitosis

Published on: March 14, 2018

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Experiment Videos

Last Updated: Jul 12, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Live Cell Imaging of Chromosome Segregation During Mitosis
06:39

Live Cell Imaging of Chromosome Segregation During Mitosis

Published on: March 14, 2018

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Area of Science:

  • Cell Biology
  • Pharmacology
  • Cancer Research

Background:

  • Lovastatin is a widely used anti-atherosclerotic drug.
  • Lovastatin is known to inhibit the cell cycle at G(1) and G(2)/M transitions.
  • The precise impact of lovastatin on mitosis requires further elucidation.

Purpose of the Study:

  • To investigate the effects of lovastatin on the process of mitosis.
  • To explore the underlying mechanisms of lovastatin-induced mitotic perturbations.

Main Methods:

  • Incubation of various cell lines (PtK(2), T24, HeLa, L929) with lovastatin (1.0-60.0 microm) for 24-48 hours.
  • Observation of mitotic perturbations using microscopy.
  • Recovery experiments in lovastatin-free media.
  • Immunofluorescence studies with anticentromeric antibodies.

Main Results:

  • Lovastatin induced diverse mitotic perturbations, including prometaphase retardation and chromosome lagging.
  • These effects were observed in epithelial and fibroblastic cell lines.
  • Mitotic disturbances were reversible upon removal of lovastatin, and mevalonic acid prevented these effects, indicating specificity.
  • Immunofluorescence suggested interference with centromere development and function.

Conclusions:

  • Lovastatin specifically inhibits mevalonic acid synthesis, leading to mitotic disorders.
  • Centromere dysfunction is a potential cause of lovastatin-induced mitotic abnormalities.
  • Lovastatin's effects on mitosis are transient and reversible.